 Short term treatment acromegaly somatostatin analog first double-blind placebo-controlled study effects Several studies somatostatin analog SMS GH hypersecretion double blind placebo-controlled study findings results randomized double clinical trial octreotide patients acromegaly drug sc initial dose micrograms micrograms day micrograms GH levels mean values observations hourly intervals insulin-like growth factor-I IGF-I levels octreotide treatment Responses reduction basal mean GH level significant reduction patients good correlation reduction GH IGF-I levels main side-effects gastrointestinal spontaneous variation daily mean GH IGF-I levels placebo group GH IGF-I levels day patients octreotide occurrence GH rises administration times desirable octreotide patients